September 15, 2025 · Form 4 insider transaction
Meisner Lara bought 15,829 shares of BICARA THERAPEUTICS INC at $5.45 per share, a transaction worth $86.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2024.